Omega Therapeutics Inc.

06/30/2022 | Press release | Distributed by Public on 06/30/2022 05:03

Omega Therapeutics Presents New Preclinical Data Supporting the First Epigenomic Controller, OTX-2002, as a Potential Therapeutic Approach in Hepatocellular Carcinoma at the[...]